Blue Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Blue Trust's AZN Position: Q3 2026 in Review
Blue Trust reduced its AstraZeneca (AZN) stake by 29% in Q3 2026, selling an estimated $850K and leaving 12,409 shares worth $2M. The position accounts for 0.02% of the portfolio, ranked #193.
Blue Trust first reported a position in AZN in Q2 2022 and has held it in 18 quarters since. The position peaked at $3.32M in Q2 2026. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Blue Trust held 12,409 shares of AstraZeneca worth $2M as of Q3 2026.
- Blue Trust sold 5,102 AstraZeneca shares in Q3 2026, an estimated $850K.
- AstraZeneca made up 0.02% of Blue Trust's portfolio in Q3 2026, its #193 holding.
- Blue Trust first reported a position in AstraZeneca in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's AstraZeneca position peaked at $3.32M in Q2 2026.
- 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.